| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.0083 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |